Oxford Bioscience Partners

Suggest edits

Follow us

Also headquartered in Boston

Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 12

Portfolio

Portfolio Tracker

Add info

Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average

Amgen Doubles Down on BeiGene Collaboration, Investing $421M More

How Amgen Dún Laoghaire is working on ‘conscious inclusion’

Amgen Sales Beat Estimates as Otezla Tested for Covid Treatment

Watch: How Amgen is committed to diversity, inclusion and belonging

How this biotech engineer became a training lead at Amgen

Adaptive Biotech’s deal with Amgen influenced by belief that COVID-19 may return seasonally, like flu

The search for a COVID-19 cure: Amgen and Adaptive Biotech partner in quest for new drug

Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning

Amgen puts its foot down in shiny new South San Francisco hub as it reorganizes R&D ops

Amgen to Cut Another 172 Jobs Following Layoff Announcement Earlier This Month

Amgen plans to eliminate another 172 jobs

Amgen cutting almost 150 jobs in Cambridge

Amgen Ends Neuroscience Research, Cuts Staff in Cambridge

Drugmaker Amgen cuts a quarter of its Kendall Square research staff

Amgen And Neuroscience

Amgen to pick up 20.5% stake in BeiGene to expand in China

Amgen exits neuroscience research, cuts 180 US jobs

Amgen Exits Neuroscience Research: The Good, Bad, And Ugly Of Biopharma

Index

By TNW

Oxford Bioscience Partners

Oxford Bioscience Partners

Overview

News

Investments 12

Portfolio

Portfolio Tracker

Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average

Amgen Doubles Down on BeiGene Collaboration, Investing $421M More

How Amgen Dún Laoghaire is working on ‘conscious inclusion’

Amgen Sales Beat Estimates as Otezla Tested for Covid Treatment

Watch: How Amgen is committed to diversity, inclusion and belonging

How this biotech engineer became a training lead at Amgen

Adaptive Biotech’s deal with Amgen influenced by belief that COVID-19 may return seasonally, like flu

The search for a COVID-19 cure: Amgen and Adaptive Biotech partner in quest for new drug

Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning

Amgen puts its foot down in shiny new South San Francisco hub as it reorganizes R&D ops

Amgen to Cut Another 172 Jobs Following Layoff Announcement Earlier This Month

Amgen chops 172 more staffers in R&D, operations and sales amid neuroscience exit, revenue ...

Amgen plans to eliminate another 172 jobs

Amgen cutting almost 150 jobs in Cambridge

Amgen Ends Neuroscience Research, Cuts Staff in Cambridge

Drugmaker Amgen cuts a quarter of its Kendall Square research staff

Amgen And Neuroscience

Amgen to pick up 20.5% stake in BeiGene to expand in China

Amgen exits neuroscience research, cuts 180 US jobs

Amgen Exits Neuroscience Research: The Good, Bad, And Ugly Of Biopharma